STOCK TITAN

Clarivate Plc (CLVT) Stock News, May-Jul 2021

CLVT NYSE

Clarivate Plc reports developments in data, analytics and workflow software for academia and government, intellectual property, and life sciences and healthcare. Its news commonly covers earnings, subscription and recurring revenue trends, cash flow and leverage actions, and progress under its operating improvement initiatives.

Company updates also focus on AI-enabled research and decision-support products, including Web of Science Research Intelligence, Nexus Connect, Cortellis Regulatory Intelligence, Derwent-based patent analytics and other Clarivate data assets. Recurring announcements address institutional research intelligence, academic library workflows, regulatory intelligence for life sciences teams, intellectual property benchmarks and investor conference appearances.

Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) will report its financial results for the second quarter 2021 on July 29, 2021, before market opening. The results, along with detailed financial information, will be available on the investor relations website. A conference call and webcast will take place on the same day at 8:00 AM ET to discuss these results. Interested parties can participate through a live audio broadcast or access a replay afterwards. For more details, visit this link.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
conferences earnings
-
Rhea-AI Summary

Clarivate (NYSE:CLVT) has launched its 2021 update of the Journal Citation Reports (JCR), providing enhanced tools for researchers and publishers. The release features data from over 20,000 journals in multiple research categories, a new Journal Citation Indicator for improved citation impact analysis, and an upgraded user interface for easier navigation. Additionally, 8,771 new journals were added, greatly expanding the available content.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
-
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) released a Global Research Report focusing on how nations and institutions respond to challenges in science and technology. The study analyzes research portfolios from G7 and BRICK nations over 1981-2018, revealing that research diversity enhances resilience, particularly during the COVID-19 pandemic. With 67,756 COVID-19 related papers indexed in 2020-21, the report illustrates how a diverse research base yields innovative solutions. The Gini coefficient was utilized for comprehensive analysis, highlighting the potential of research diversity as a strategic tool for investment planning.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
none
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) announced the pricing of a $1.0 billion private offering of 3.875% senior secured notes due 2028 and $1.0 billion of 4.875% senior notes due 2029. The offering's proceeds will finance the acquisition of ProQuest, set to finalize by November 8, 2021, and cover associated fees. The notes will not be guaranteed before the acquisition but will be secured by escrow accounts. The offering is intended for qualified institutional buyers, with interests payable semi-annually starting December 30, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
debt offering offering
-
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) announced a private offering of up to $1.0 billion in senior secured notes due 2028 and $1.0 billion in senior unsecured notes due 2029. The offering, subject to market conditions, aims to finance the purchase price for the pending acquisition of ProQuest, announced on May 17, 2021. The proceeds will be held in escrow until acquisition conditions are met, with redemption provisions if conditions are not satisfied by November 8, 2021. The notes will be secured prior to acquisition completion and will be guaranteed by subsidiaries post-acquisition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
debt offering offering
-
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) has priced concurrent offerings of 38,461,538 ordinary shares at $26.00 each and 12,500,000 5.25% Series A Mandatory Convertible preferred shares at $100 each. The offerings are expected to close on June 14, 2021. The company anticipates net proceeds of approximately $723.8 million from the ordinary shares and $1.208 billion from the preferred shares. The funds will primarily finance the pending acquisition of ProQuest, announced on May 17, 2021. The convertible preferred shares will convert into ordinary shares on June 1, 2024, if not redeemed earlier.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.44%
Tags
none
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) announced on June 8, 2021, the proposed offerings of $750 million in ordinary shares and $1.25 billion in Series A Mandatory Convertible preferred shares. These offerings, which total $2 billion, aim to finance its pending acquisition of ProQuest. The completion of either offering is independent and subject to market conditions. If the acquisition does not proceed, proceeds will be used for general corporate purposes. The convertible preferred shares will convert into ordinary shares on June 1, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.59%
Tags
none
-
Rhea-AI Summary

Clarivate Plc (NYSE:CLVT) has launched the COVID-19 Vaccine Availability and Medtech Impact Report, forecasting vaccination rates across countries in 2021. The report indicates that vaccine acceptance varies by region, with rates of 94% in Malaysia and 71% in the U.S. It highlights the importance of vaccination in recovering healthcare markets post-pandemic, particularly for Ambulatory Surgery Centers (ASCs) which showed higher utilization rates. The predictive analysis leverages real-world data to aid healthcare stakeholders in planning and decision-making.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.26%
Tags
covid-19
-
Rhea-AI Summary

Clarivate Plc (NYSE: CLVT) has announced a commercial partnership with Explore IP to integrate Derwent™ patent data into its platform. This collaboration aims to enhance the searchability of intellectual property data, enabling businesses and innovators to identify and understand patents held by Canadian public sector institutions. The partnership will facilitate licensing opportunities and foster innovation by providing access to authoritative patent information. This integration will support Canadian entrepreneurs and significantly improve the marketability of public sector technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
partnership
Rhea-AI Summary

On May 26, 2021, Clarivate Plc (NYSE: CLVT) announced that its Executive Chairman and CEO, Jerre Stead, along with CFO Richard Hanks, will present at three upcoming virtual investor conferences in June 2021. The conferences include: William Blair's 41st Annual Growth Stock Conference on June 2 at 10:00 am CT, Baird's 2021 Global Consumer, Technology & Services Conference on June 8 at 12:15 pm ET, and Stifel's 2021 Virtual Cross Sector Insight Conference on June 10 at 8:00 am ET. Live webcasts will be available for each event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
conferences

FAQ

What is the current stock price of Clarivate (CLVT)?

Clarivate (CLVT) last closed at $2.32.

What is the market cap of Clarivate (CLVT)?

The market cap of Clarivate (CLVT) is approximately $1.5B.